- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05397275
The Effect of Progressive Relaxation and Breathing Exercise on Sleep Quality and Exercise Self-Efficacy in Patients With COPD
Aim: This study was conducted to determine the effect of progressive muscle relaxation and breathing exercise on sleep quality and exercise self-efficacy in chronic obstructive pulmonary patients.
Methods: This study was conducted as a randomized controlled experimental study. The study was conducted with 64 chronic obstructive pulmonary patients, where 36 of them were in the intervention group and 34 in the control group. Data of the study were collected using the descriptive information form, the Pittsburgh Sleep Quality Index, and the Exercise Self-Regulatory Efficacy Scale (Ex-SRES) for patients with COPD.
Results: When the total scores pertaining to the sleep quality index and exercise self-efficacy of the individuals in the intervention and control groups were compared, it was found that there were statistically significant differences in the intervention group compared to the control group (p < 0.05).
Keywords: Exercise Self-Regulatory Efficacy, sleep quality in patients with COPD, PGE along with breathing exercises, pulmonary rehabilitation
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aksaray, Turkey
- Aksaray University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- were to be 18 years of age or older
- not using sleeping pills
- verbally stating that they have moderate and severe sleep disorders.
Exclusion Criteria:
- having any lung disease other than COPD
- having cardiological problems (heart failure, uncontrollable hypertension, history of angina and myocardial infarction, heart valve problems), psychotic disorder,
- inability to communicate verbally and having hearing problems.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental group
progressive muscle relaxation exercises + breathing exercise
|
progressive muscle relaxation+breathe exercises
|
|
Experimental: control group
only breathing exercise
|
breathe exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
progressive muscle relaxation exercises changes sleep quality and exercise self-efficacy.
Time Frame: 1 mounth
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index as an pre- test and 4 weeks later as a post-test test.
|
1 mounth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
progressive muscle relaxation exercises with breathing exercise changes sleep quality and exercise self-efficacy.
Time Frame: 1 mounth
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index as an pre-test and 4 weeks later as a post-test. .The Exercise Self-Regulatory Efficacy Scale will be used as a pre-test and after 4 weeks as a post-test to measure the exercise capacity of COPD patients. |
1 mounth
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Osmaniye Korkut Ata University
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD Asthma
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Union Hospital, Tongji Medical College, Huazhong...Not yet recruitingSevere Eosinophilic ACOS (Asthma-COPD Overlap)China
-
University Hospital, BordeauxActive, not recruiting
-
University of ChicagoCompleted
-
Rush University Medical CenterPeople's Liberation Army General HospitalCompleted
-
Universidade Federal do Rio Grande do NorteUnknown
-
Respivert LtdBabraham Institute Enterprise LimitedCompletedAsthma | COPDUnited Kingdom
-
University of SouthamptonUniversity Hospital Southampton NHS Foundation Trust; University of Birmingham and other collaboratorsCompleted
-
Mylan Pharma UK Ltd.CompletedAsthma | COPDUnited States
-
Intech Biopharm Ltd.Completed
Clinical Trials on progressive muscle relaxation+breathe exercises
-
Ataturk UniversityCompletedStress | Anxiety | Nursing Students | Relaxation ProgramTurkey
-
KTO Karatay UniversityNot yet recruiting
-
Istanbul Medeniyet UniversitySaglik Bilimleri UniversitesiRecruitingSpinal Stenosis LumbarTurkey
-
Halic UniversityCompletedWomen With Low Sexual Satisfaction | Partners of Women With Low Sexual SatisfactionTurkey
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Istanbul Sabahattin Zaim UniversityEnrolling by invitationLymphoma PatientsTurkey
-
Gazi UniversityCompletedRestless Legs SyndromeTurkey
-
Atlas UniversityCompletedDementia | Caregiver BurdenTurkey
-
Cairo UniversityCompleted
-
Riphah International UniversityCompletedAnxiety | Pain SyndromePakistan